Mechanism of CD1d-restricted natural killer T cell activation during microbial infection

被引:0
|
作者
Manfred Brigl
Lynn Bry
Sally C Kent
Jenny E Gumperz
Michael B Brenner
机构
[1] Immunology,Division of Rheumatology
[2] and Allergy,Department of Pathology
[3] Brigham and Women's Hospital and Harvard Medical School,undefined
[4] Brigham and Women's Hospital and Harvard Medical School,undefined
[5] Center for Neurologic Diseases,undefined
[6] Brigham and Women's Hospital and Harvard Medical School,undefined
来源
Nature Immunology | 2003年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
CD1d-restricted natural killer T (NKT) cells are important for host defense against a variety of microbial pathogens. How and when these T cells become activated physiologically during infection remains unknown. Our data support a model in which NKT cells use a unique activation mechanism not requiring their recognition of microbial antigens. Instead, weak responses to CD1d-presented self antigens were amplified by interleukin 12 made by dendritic cells in response to microbial products, resulting in potent interferon-γ secretion. NKT cells were among the first lymphocytes to respond during Salmonella typhimurium infection, and their activation in vivo also depended on interleukin 12 and CD1d recognition. We propose this mechanism of activation as a major pathway responsible for the rapid activation of NKT cells in different microbial infections.
引用
收藏
页码:1230 / 1237
页数:7
相关论文
共 50 条
  • [21] CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
    Spada, FM
    Koezuka, Y
    Porcelli, SA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08): : 1529 - 1534
  • [22] Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions
    Aslanian, AM
    Chapman, HA
    Charo, IF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) : 628 - 632
  • [23] Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma
    Licun Wu
    Zhihong Yun
    Tetsuzo Tagawa
    Luis De la Maza
    Matthew Onn Wu
    Julie Yu
    Yidan Zhao
    Marc de Perrot
    Cancer Immunology, Immunotherapy, 2014, 63 : 1285 - 1296
  • [24] CD1d-restricted help to B cells by human invariant natural killer T lymphocytes
    Galli, G
    Nuti, S
    Tavarini, S
    Galli-Stampino, L
    De Lalla, C
    Casorati, G
    Dellabona, P
    Abrignani, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08): : 1051 - 1057
  • [25] CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice
    Ishikawa, Sachiko
    Ikejima, Kenichi
    Yamagata, Hisafumi
    Aoyama, Tomonori
    Kon, Kazuyoshi
    Arai, Kumiko
    Takeda, Kazuyoshi
    Watanabe, Sumio
    JOURNAL OF HEPATOLOGY, 2011, 54 (06) : 1195 - 1204
  • [26] Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma
    Wu, Licun
    Yun, Zhihong
    Tagawa, Tetsuzo
    De la Maza, Luis
    Wu, Matthew Onn
    Yu, Julie
    Zhao, Yidan
    de Perrot, Marc
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (12) : 1285 - 1296
  • [27] Early Alterations in Endogenous Hepatocyte Lipid Antigens in Hepatitis B Virus Infection Are Associated With CD1D-Restricted Natural Killer T Cell Activation and Viral Clearance
    Zeissig, Sebastian
    Murata, Kazumoto
    Hu, Zongyi
    Kaser, Arthur
    Dougan, Stephanie K.
    Bosse, Esther
    Scapa, Erez E.
    Cohen, David E.
    Arli, Alexander
    Franke, Andre
    Schreiber, Stefan
    Liang, T. Jake
    Blumberg, Richard S.
    GASTROENTEROLOGY, 2011, 140 (05) : S886 - S886
  • [28] Mechanism of Premature Apoptosis in CD1d-Restricted Natural Killer T Cells From Human Peripheral Blood During the Induction of Proliferation In Vitro
    Gao, L.
    Fan, Y.
    Yang, Y.
    Xie, R.
    Yang, J.
    Chen, Z.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1514 - 1518
  • [29] Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases
    Miyake, Sachiko
    Yamamura, Takashi
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2007, 26 (1-2) : 73 - 94
  • [30] Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets
    Rolf, Julia
    Berntman, Emma
    Stenstroem, Martin
    Smith, Emma M. K.
    Mansson, Robert
    Stenstad, Hanna
    Yamagata, Tetsuya
    Agace, William
    Sigvardsson, Mikael
    Cardell, Susanna L.
    MOLECULAR IMMUNOLOGY, 2008, 45 (09) : 2607 - 2620